Publications by authors named "Tara Baetz"

Claim this Profile
E
Efficacy and safety of adjuvant systemic therapies in trial non-eligible resected stages III and IV melanoma patients.
Sarah Alsadiq, Adi Kartolo, Elaine McWhirter, Wilma Hopman, Tara Baetz

Melanoma Manag· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive Melanoma Arising in a BAP1-Inactivated Melanocytic Tumor With NRAS Mutation: A Report of Exceptional Case With Emphasis on Its Genomic Features and Review of the Literature.
Muath Alyahya, Nyi Nyi May-Phyo, Ami Wang, Shamini Selvarajah, Cuihong Wei, Tara Baetz

J Cutan Pathol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma.
Michael P MacManus, John F Seymour, Hennes Tsang, Richard Fisher, Colm Keane, Tara Baetz

EBioMedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy.
Samantha A Hershenfeld, Josuha W D Tobin, Victoria Shelton, Lourdes Calvente, Katherine Lajkosz, Tara Baetz

Br J Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP.
Douglas A Stewart, John Kuruvilla, David Lee, Jill J Dudebout, Neil Chua, Tara Baetz

Br J Haematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of genetic subtypes in follicular lymphoma.
Victoria Shelton, Rajesh Detroja, Ting Liu, Keren Isaev, Anjali Silva, Tara Baetz

Blood Cancer J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance evaluations in patients with stage I, II, III, or resectable IV melanoma who were treated with curative intent: A systematic review.
Sudha Rajagopal, Xiaomei Yao, Wadid Abadir, Tara D Baetz, Alexandra Easson

Surg Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of circadian timing of initial infusions of immune checkpoint inhibitors with survival in advanced melanoma.
Cynthia Yeung, Adi Kartolo, Justin Tong, Wilma Hopman, Tara Baetz

Immunotherapy· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survivals following discontinuation of PD-1 inhibitor treatment in advanced melanoma patients.
Adi Kartolo, Justin Tong, Cynthia Yeung, Markus Kuksis, Wilma Hopman, Tara Baetz

Melanoma Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of TCF3 target genes defines a subclass of diffuse large B-cell lymphoma characterized by up-regulation of MYC target genes and poor clinical outcome following R-CHOP therapy.
Kathrin Tyryshkin, Alison Moore, David Good, Jesse Popov, Susan Crocker, Tara Baetz

Leuk Lymphoma· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Toxicities of Immune Checkpoint Inhibitor (ICI) in Melanoma Patients.
Justin Tong, Adi Kartolo, Cynthia Yeung, Wilma Hopman, Tara Baetz

Curr Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete response and survival outcomes in patients with advanced cancer on immune checkpoint inhibitors.
Adi Kartolo, Cynthia Yeung, Wilma Hopman, Andrea S Fung, Tara Baetz

Immunotherapy· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No association between BMI and immunotoxicity or clinical outcomes for immune checkpoint inhibitors.
Cynthia Yeung, Adi Kartolo, Ryan Holstead, Gordon Taylor Moffat, Lilian Hanna, Tara Baetz

Immunotherapy· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population-based validation study of the 8th edition UICC/AJCC TNM staging system for cutaneous melanoma.
Matthew C Hynes, Paul Nguyen, Patti A Groome, Yuka Asai, Meaghan E Mavor, Tara D Baetz

BMC Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved overall survival in dual compared to single immune checkpoint inhibitors in V600-negative advanced melanoma.
Adi Kartolo, Cynthia Yeung, Markus Kuksis, Wilma Hopman, Tara Baetz

Melanoma Manag· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma.
Adi Kartolo, Jasna Deluce, Wilma M Hopman, Linda Liu, Tara Baetz

Curr Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Clinical Outcomes of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Diseases.
Cynthia Yeung, Adi Kartolo, Ryan Holstead, Gordon T Moffat, Lilian Hanna, Tara Baetz

J Immunother· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous thromboembolism events in patients with advanced cancer on immune checkpoint inhibitors.
Adi Kartolo, Cynthia Yeung, Gordon T Moffat, Lilian Hanna, Wilma Hopman, Tara Baetz

Immunotherapy· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the development of immune related adverse events in metastatic melanoma treated with PD -1 inhibitors.
Ryan G Holstead, Baskoro A Kartolo, Wilma M Hopman, Tara D Baetz

Melanoma Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Baseline Corticosteroids on Immunotherapy Efficacy in Patients With Advanced Melanoma.
Adi Kartolo, Jasna Deluce, Ryan Holstead, Wilma Hopman, John Lenehan, Tara Baetz

J Immunother· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosticating role of serum eosinophils on immunotherapy efficacy in patients with advanced melanoma.
Adi Kartolo, Ryan Holstead, Wilma Hopman, Tara Baetz

Immunotherapy· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Immunotherapy Rechallenge After Immune-related Adverse Events in Patients With Advanced Cancer.
Adi Kartolo, Ryan Holstead, Sidra Khalid, Jeffrey Emack, Wilma Hopman, Tara Baetz

J Immunother· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency Department Utilization for Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Analysis of Identification and Outcomes for Those Presenting for Immune-Related Adverse Events.
Ryan Holstead, Adi Kartolo, Tara Baetz

Curr Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in prognosticating immunotherapy efficacy.
Adi Kartolo, Ryan Holstead, Sidra Khalid, Jeffrey Emack, Wilma Hopman, Tara Baetz

Immunotherapy· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Innovations in Radiotherapy and Systemic Treatments With Clinical Outcomes in Patients With Melanoma Brain Metastasis From 2007 to 2016.
Harry C Brastianos, Paul Nguyen, Arjun Sahgal, Elizabeth A Eisenhauer, Tara Baetz

JAMA Netw Open· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis